NOV 17, 202653 MINS READ
The synthesis of creatine phosphate relies on a defined set of chemical precursors, each contributing specific functional groups essential for constructing the phosphoguanidino moiety. The primary raw materials include creatinine (C₄H₇N₃O, molecular weight 113.12 g/mol), phosphorus oxychloride (POCl₃), creatine (C₄H₉N₃O₂), and sarcosine (N-methylglycine, C₃H₇NO₂)1,2,3. Creatinine serves as a cyclic precursor that, upon phosphorylation and subsequent alkaline hydrolysis, yields creatine phosphate with high atom economy1,6. Phosphorus oxychloride acts as the phosphorylating agent, introducing the phosphate group via formation of intermediate phosphoryl chlorides such as creatinine phosphoryl chloride1,3,6. Alternative phosphorylating reagents include diphenyl phosphorochloridate, which offers milder reaction conditions but higher cost1.
Creatine itself can be directly phosphorylated under strongly alkaline conditions (pH 12–14) using POCl₃, though this route suffers from lower yields (typically 40–60%) and requires rigorous control of reaction temperature (0–5°C) to minimize side reactions2,13. Sarcosine (sodium or potassium sarcosinate) is employed in enzymatic and chemical routes where it condenses with cyanamide or S-methylisothiourea to form creatine, which is subsequently phosphorylated2,4,5. The enzymatic route using rabbit muscle extract containing creatine phosphokinase, enolase, phosphoglycerate mutase, and pyruvate kinase achieves yields of 300–350 g creatine phosphate per 100 L batch, with enzyme loadings of 50,000–80,000 units of creatine phosphokinase2. However, enzymatic methods face challenges in enzyme recovery and protein contamination, limiting industrial scalability2,6.
Key structural considerations include the stability of creatinine in acidic versus alkaline media: creatinine is prone to ring-opening hydrolysis at pH >10, which is exploited in the final step to convert creatinine phosphate to creatine phosphate1,3,6. The purity of starting creatinine must exceed 98% (HPLC) to avoid accumulation of guanidino impurities that co-crystallize with the product3,6. Phosphorus oxychloride must be anhydrous (>99.5% purity) to prevent premature hydrolysis and formation of phosphoric acid, which reduces phosphorylation efficiency1,3,9.
The predominant industrial route involves three sequential steps1,3,6,9:
Step 1: Condensation of creatinine with POCl₃. Creatinine (1 equivalent) is suspended in anhydrous acetone or tetrahydrofuran, and POCl₃ (0.5–0.8 equivalents) is added dropwise at 0–10°C under nitrogen atmosphere1,3. The reaction proceeds for 20–30 hours at reflux (56–66°C for THF), forming creatinine phosphoryl chloride as a white crystalline intermediate. Excess POCl₃ is removed by vacuum distillation at <40°C to prevent thermal decomposition1,6. Typical yields of crude creatinine phosphoryl chloride are 70–85%3,6.
Step 2: Purification of creatinine phosphoryl chloride. The crude intermediate is dissolved in halogenated solvents (dichloromethane or chloroform, 50–100 mL per 10 g intermediate) at 20–25°C, filtered to remove insoluble salts, and then precipitated by addition of aliphatic hydrocarbons (n-hexane or petroleum ether, 2–3 volumes) at 0–5°C3. Recrystallization yields purified creatinine phosphoryl chloride with purity >95% (HPLC), free from heavy metal contamination (<10 ppm)3,6. This purification step is critical: unpurified intermediates contain residual POCl₃ and chloride salts that interfere with subsequent hydrolysis and ion-exchange purification3,6.
Step 3: Alkaline hydrolysis to creatine phosphate disodium salt. Purified creatinine phosphoryl chloride (1 equivalent) is added portionwise to ice-cold aqueous NaOH (50 g NaOH per 66 g intermediate, in 730 mL water, pH >13) at 0–5°C3,6,9. The mixture is stirred for 30 minutes at 0°C, then warmed to 45°C and maintained for 16 hours to complete ring-opening hydrolysis3,6. The reaction is monitored by ³¹P NMR: disappearance of the signal at δ = 3.5 ppm (creatinine phosphate) and appearance of δ = 2.8 ppm (creatine phosphate) indicates completion6. The solution is cooled to 10°C, adjusted to pH 8.0 with 1 N HCl, treated with activated carbon (10% w/w) for decolorization, and filtered3,6. Addition of 4–5 volumes of ethanol precipitates crude creatine phosphate disodium tetrahydrate, which is collected by filtration, washed with anhydrous ethanol, and dried under vacuum at 25–45°C3,6. Crude yields are 80–90%; recrystallization from water/ethanol affords final product with purity ≥99.2% (anhydrous basis) and related substances <0.1% by HPLC3,6.
An alternative enzymatic route employs rabbit muscle extract as a biocatalyst2. Creatine (260 g) is dissolved in 100 L water with ATP (15 g as disodium dihydrate), 3-phosphoglyceric acid sodium (380 g), magnesium acetate (14 g), potassium acetate (17 g), and ammonium acetate (80 g) at pH 8.5 and 37°C2. The enzyme mixture (containing ~80,000 units creatine phosphokinase, 100,000 units enolase, 100,000 units phosphoglycerate mutase, and 250,000 units pyruvate kinase) is added, and the reaction proceeds for 1–3 hours with pH maintained at 8.52. After heating to 80–90°C to denature proteins, the solution is passed through a sodium-form cation exchanger (Amberlite IR-120 or Dowex 50, 10 L resin per 100 L batch), concentrated to 4–6 L, and precipitated with 8–12 L ethanol2. Crystalline creatine phosphate disodium hexahydrate is obtained in yields of 300–350 g per batch (corresponding to ~70% based on creatine)2. This method avoids toxic phosphorylating agents but requires costly enzymes and extensive protein removal steps, limiting its industrial adoption2,6.
Recent patents emphasize barium-free synthesis to eliminate heavy metal contamination9,10. One approach converts POCl₃ to chlorophosphoric acid (H₂PO₃Cl) by controlled hydrolysis at 0–10°C, which then reacts with S-methylisothiourea sulfate in aprotic solvents (DMF or DMSO) to form phosphorylated S-methylisothiourea9. This intermediate is hydrolyzed with sarcosine at pH 8–9 and 30–35°C for 6 hours, yielding creatine phosphate disodium with 84% overall yield and purity >99.7%9. Another method forms a lipophilic creatinine phosphate carboxylic anhydride by reacting creatinine phosphoryl chloride with carboxylate salts (e.g., sodium isooctanoate) in ethyl acetate at 0–5°C10. Subsequent hydrolysis with aqueous NaOH at 80°C for 15 minutes, followed by neutralization with acetic acid and ethanol precipitation, affords creatine phosphate disodium with purity >99% and no detectable heavy metals (<0.5 ppm)10. These routes reduce environmental impact (no barium waste) and simplify downstream purification9,10.
Crude creatine phosphate solutions contain colored impurities (melanoidins from Maillard reactions during alkaline hydrolysis) and residual salts (chloride, sulfate)2,3,6. Passage through a strong-acid cation exchanger in sodium form (e.g., Amberlite IR-120, 10 L resin per 100 L solution, pre-equilibrated to pH 8–9 with NaOH) removes divalent cations (Ca²⁺, Mg²⁺) and protonated guanidino impurities2,6. The eluate is treated with activated carbon (1–10% w/w) at 20–80°C for 30–60 minutes to adsorb colored compounds, then filtered through a 0.45 μm membrane3,6. Decolorization efficiency is monitored by UV-Vis absorbance at 420 nm: final solutions should have A₄₂₀ <0.05 (1 cm path, 10% w/v solution)6.
Creatine phosphate disodium crystallizes as the tetrahydrate (C₄H₈N₃Na₂O₅P·4H₂O, molecular weight 327.14 g/mol) or hexahydrate depending on ethanol concentration and temperature2,3,6. For tetrahydrate formation, the purified aqueous solution (10–15% w/v creatine phosphate) is mixed with 4–5 volumes of ethanol at 10–20°C, seeded with authentic crystals, and aged for 6–12 hours at 4°C3,6. Crystals are collected by vacuum filtration, washed with cold anhydrous ethanol (2–3 bed volumes), and dried at 25–45°C under vacuum (<10 mbar) for 12–24 hours3,6. Over-drying at >50°C causes partial dehydration and formation of amorphous phases with reduced solubility6. Recrystallization from water/ethanol (1:1.5 v/v) at 20°C improves purity to ≥99.6% (HPLC) and reduces related substances to <0.1%3,6. Particle size is controlled by crystallization temperature and agitation rate: slow cooling (0.5°C/h) and low agitation (50–100 rpm) yield coarse crystals (40 mesh, 95% pass) suitable for tableting, whereas rapid cooling and high agitation produce fine powders for injectable formulations7.
Pharmaceutical-grade creatine phosphate disodium must meet stringent specifications3,6:
Compliance with ICH Q3D guidelines for elemental impurities and USP <232>/<233> is mandatory for pharmaceutical applications6. For nutraceutical use, products must meet FDA GRAS standards and EU Novel Food Regulation (EC) No 258/974,5.
Industrial synthesis of creatine phosphate disodium is conducted in glass-lined or Hastelloy reactors (500–2000 L capacity) equipped with efficient agitation (Rushton turbines, 100–200 rpm), temperature control (jacketed vessels with ethylene glycol circulation, ±2°C precision), and inert atmosphere (nitrogen purge, <50 ppm O₂)1,3,6. The exothermic condensation of creatinine with POCl₃ (ΔH ≈ -45 kJ/mol) requires controlled addition rates (0.1–0.2 mol POCl₃ per minute per 1000 L reactor volume) to maintain temperature at 0–10°C and prevent runaway polymerization1,3. Heat removal capacity must exceed 15 kW per 1000 L to handle peak exotherms3. Reflux condensers with caustic scrubbers (20% NaOH) capture HCl vapors generated during phosphorylation (1 mol HCl per mol POCl₃ consumed)1,3,6.
Alkaline hydrolysis is conducted in stainless steel reactors (pH >13 is corrosive to glass linings) with high-shear mixing (300–500 rpm) to ensure rapid dissolution of creatinine phosphoryl chloride and uniform pH distribution3,6,9. Temperature ramps are programmed (0°C for 30 min, then 1°C/min to 45°C, hold 16 h) to balance hydrolysis kinetics (faster at higher T) against thermal degradation of creatine phosphate (t₁/₂ ≈ 48 h at 45°C, pH 8)3,6. Real-time pH monitoring (glass electrode with automatic NaOH/HCl dosing, ±0.1 pH unit) prevents localized acidification that converts creatine phosphate to creatine and inorganic phosphate6,9.
Phosphorus oxychloride is a highly reactive, corrosive liquid (b.p. 105.5°C, vapor pressure 40 mmHg at 27.3°C) that hydrolyzes violently with water to release HCl and heat1,3. Handling requires closed transfer systems (pressure-equalized addition funnels or peristaltic pumps), secondary containment (stainless steel drip pans), and personal protective equipment (full-face respirators with acid-gas cartridges, neoprene gloves, chemical-resistant aprons)1,3. Emergency sh
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| BOEHRINGER MANNHEIM GMBH. | Pharmaceutical production requiring high-purity creatine phosphate without heavy metal contamination for injectable cardioprotective formulations. | Creatine Phosphate Enzymatic Synthesis System | Enzymatic route using rabbit muscle extract achieves yields of 300-350g creatine phosphate per 100L batch with enzyme loadings of 50,000-80,000 units of creatine phosphokinase, avoiding toxic phosphorylating agents. |
| NANJING CUCCESS PHARMACEUTICAL CO. LTD. | Industrial-scale pharmaceutical manufacturing requiring environmentally compliant processes and heavy-metal-free creatine phosphate for clinical applications. | Barium-Free Creatine Phosphate Production Process | Converts POCl₃ to chlorophosphoric acid for phosphorylation, achieving 84% overall yield with purity >99.7% and no detectable heavy metals (<0.5 ppm), eliminating barium waste. |
| ZHONGSHAN BELLING BIO TECHNOLOGY CO. LTD. | Pharmaceutical-grade creatine phosphate production for injectable drugs requiring stringent purity specifications and reduced processing time. | High-Purity Creatine Phosphate Synthesis via Lipophilic Intermediates | Forms lipophilic creatinine phosphate carboxylic anhydride intermediate, yielding creatine phosphate disodium with purity >99% through simplified purification and shortened production cycles. |
| BASF AKTIENGESELLSCHAFT | Nutraceutical and sports nutrition applications requiring coarse-grained creatine with low electrostatic charging and minimal caking for consumer supplements. | Creatine Purification Process | Recrystallization from water/ethanol achieves creatine monohydrate purity ≥99.6% with controlled particle size (40 mesh, 95% pass) suitable for tableting and reduced dust formation. |
| XENOPORT INC. | Clinical therapeutics for cardioprotection and neuroprotection requiring enhanced membrane permeability and targeted intracellular delivery of high-energy phosphates. | Membrane-Permeable Creatine Phosphate Prodrugs | Prodrug formulations enhance cellular uptake and bioavailability of creatine phosphate for improved efficacy in treating ischemia, heart failure, and neurodegenerative disorders. |